Cargando…

Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Atherosclerosis: Possible Correlation with Clinical Presentation

Receptor for Advanced Glycation End-products (RAGE) is a multi-ligand receptor ubiquitous present on epithelial, neuronal, vascular and inflammatory cells, usually expressed at low levels in homeostasis and to increased degrees at sites of stress or injury. The aim of the present study was to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falcone, Colomba, Bozzini, Sara, D'Angelo, Angela, Matrone, Benedetta, Colonna, Anna, Benzi, Alberto, Paganini, Edoardo Maria, Falcone, Rossana, Pelissero, Gabriele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774980/ https://www.ncbi.nlm.nih.gov/pubmed/24167358 http://dx.doi.org/10.1155/2013/129360

Ejemplares similares

Possible Role of –374T/A Polymorphism of RAGE Gene in Longevity
por: Falcone, Colomba, et al.
Publicado: (2013)

Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
por: Falcone, Colomba, et al.
Publicado: (2013)

Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects
por: Emanuele, Enzo, et al.
Publicado: (2003)

Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes
por: Gazzaruso, Carmine, et al.
Publicado: (2016)

Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT
por: Falcone, Colomba, et al.
Publicado: (2012)

Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis: Observations from the Dallas Heart Study
por: Lindsey, Jason B., et al.
Publicado: (2009)

Transcutaneous Oxygen Tension as a Potential Predictor of Cardiovascular Events in Type 2 Diabetes: Comparison with ankle-brachial index
por: Gazzaruso, Carmine, et al.
Publicado: (2013)

Plasma Advanced Glycation End Products and Dicarbonyl Compounds Are Not Associated with Coronary Atherosclerosis in Athletes
por: BERGE, KRISTIAN, et al.
Publicado: (2023)

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
por: Jensen, Louise J. N., et al.
Publicado: (2015)

The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease
por: Wang, Xiangming, et al.
Publicado: (2019)

Soluble receptor for advanced glycation end-products and progression of airway disease
por: Iwamoto, Hiroshi, et al.
Publicado: (2014)

Impact of Serum High Mobility Group Box 1 and Soluble Receptor for Advanced Glycation End-Products on Subclinical Atherosclerosis in Patients with Granulomatosis with Polyangiitis
por: de Souza, Alexandre W. S., et al.
Publicado: (2014)

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
por: Yamagishi, Sho-ichi, et al.
Publicado: (2018)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer’s Disease
por: Ko, Shun-Yao, et al.
Publicado: (2015)

Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism
por: Gazzaruso, Carmine, et al.
Publicado: (2002)

Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
por: Liu, Heliang, et al.
Publicado: (2020)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study
por: Maruthur, Nisa M., et al.
Publicado: (2015)

sRAGE and early signs of cardiac target organ damage in mild hypertensives
por: Maresca, Andrea Maria, et al.
Publicado: (2019)

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
por: Mao, Lin, et al.
Publicado: (2022)

Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women
por: Ghosh, Soumitra, et al.
Publicado: (2021)

Polyionic Tags as Enhancers of Protein Solubility in Recombinant Protein Expression
por: Paraskevopoulou, Vasiliki, et al.
Publicado: (2018)

Serum Adiponectin, Resistin, and Circulating Soluble Receptor for Advanced Glycation End Products in Colectomy Patients
por: Asgeirsson, Theodor, et al.
Publicado: (2011)

Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus
por: Škrha, J., et al.
Publicado: (2013)

Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2018)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
por: Hoffman, William H., et al.
Publicado: (2020)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
por: Wu, Shou-En, et al.
Publicado: (2021)

A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer
por: Wendel, Ulrika, et al.
Publicado: (2018)

Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling
por: Gao, Hongli, et al.
Publicado: (2017)

Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2013)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
por: Assiri, Adel M. A., et al.
Publicado: (2018)

Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly Subjects
por: Kotani, Kazuhiko, et al.
Publicado: (2011)

Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery
por: Tuinman, Pieter R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ndd5en7e0lvem9m8ln4dpg03vc